Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
CERS
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Cathie Wood sells $11.6 million of surging tech stock
Cathie Wood, chief of Ark Investment Management, often locks in gains when her favorite tech stocks surge. That's what she's doing with Palantir Technologies (PLTR), trimming her position after the stock jumped more than 30% over the past…
In trading on Friday, the Goldman Sachs MarketBeta Total International Equity ETF is outperforming other ETFs, up about 2.9% on the day. Components of that ETF showing particular strength include shares of Vista Energy, up about 1.2% and s…
Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M
Cerus Corporation (NASDAQ:CERS) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 8, Cerus Corporation (NASDAQ:CERS) closed a new debt facility with MidCap Financial, providing up to $110 million. The firm combined…
Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has BrightSpring Health Services, Inc. (BTSG) been one of those stocks this year? By taking a look at the stock's year-to-d…
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG
Cerus Corporation (NASDAQ:CERS) is one of the best oversold growth stocks to invest in now. BTIG upgraded Cerus Corporation (NASDAQ:CERS) to Buy from Neutral on May 1, reiterating a $4 price target. The rating update came after the company…
3 Penny Stocks With Market Caps Under $500M And Promising Growth
Over the last 7 days, the United States market has dropped by 1.0%, but it remains up 23% over the past year, with earnings forecasted to grow by 17% annually. In such a dynamic landscape, identifying stocks that combine value and growth p…
Epistrophy Capital Research Chief Market Strategist and The Drill Down Podcast host Cory Johnson joins Market Catalysts to discuss the Cerebras IPO and key factors to watch in Nvidia’s (NVDA) upcoming earnings report. Video Transcript 00:0…
Image source: The Motley Fool. DATE Thursday, April 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Obi Greenman Chief Operating Officer, Incoming President and Chief Executive Officer — Vivek K. Jayarama…
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: * Apple (AAPL [https://seekingalpha.com/symbol/AAPL]) * Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]) * Roku (ROKU [https://seekingalpha.com/symbol/ROKU]) * Twilio (TWLO [ht…
Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors
The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock' may seem outdated, it still represents…
Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks
In a volatile market, savvy investors like Cathie Wood take the opportunity to accumulate shares of companies with long-term potential. As the founder and CEO of ARK Invest, Wood is known for her high-conviction strategy centered on disrup…
Cerus logo Key Points Record 2025 revenue: Cerus reported total 2025 revenue of $233.8 million (up 16%) with product revenue beating guidance, narrowed GAAP net loss, seven consecutive quarters of positive adjusted EBITDA, and reaffirmed 2…
Here are the major earnings after the close Monday
Major earnings expected after the bell on Monday include: * Plug Power (PLUG [https://seekingalpha.com/symbol/PLUG]) * Archer Aviation (ACHR [https://seekingalpha.com/symbol/ACHR]) * Credo Technology Group Holding Ltd (CRDO [https://seekin…
* Cerus (CERS [https://seekingalpha.com/symbol/CERS]) is scheduled to announce Q4 earnings results on Monday, March 2nd, after market close. The consensus EPS Estimate is -$0.01 [https://seekingalpha.com/symbol/CERS/earnings/estimates] (fl…
As February 2026 begins, U.S. stock markets have shown a strong start with major indexes like the Dow Jones and S&P 500 posting significant gains. This positive momentum sets an intriguing backdrop for investors exploring various segments…
After-Hours Biotech Rally: SXTC, RPID, TGTX Lead Gains On Revenue Updates, And FDA Milestones
(RTTNews) - Several biotechnology and pharmaceutical names posted notable gains in Tuesday's after-hours trading session, driven by corporate updates and investor enthusiasm around clinical and financial milestones. China SXT Pharmaceutica…
3 Promising Penny Stocks With Market Caps Over $100M
As the S&P 500 and Dow Jones Industrial Average reach new highs, investors are looking beyond the headlines to explore diverse investment opportunities. Penny stocks, though often overlooked in favor of larger market players, continue to o…
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS)
Cerus Corporation (NASDAQ:CERS) is among the Best Get Rich Fast Stocks to Buy Right Now. On December 23, TheFly reported that TD Cowen views Cerus Corporation (NASDAQ:CERS)’s Intercept Fibrinogen Complex franchise as an “underappreciated”…
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying
(RTTNews) - U.S. after-hours trading on Wednesday saw a wave of gains across several small-cap and micro-cap biotech names, with a mix of catalyst-driven moves and sentiment-based rebounds. While a few companies advanced on upcoming clinic…
3 Promising Penny Stocks With Market Caps Under $400M
As the U.S. stock market grapples with recent volatility, highlighted by the Nasdaq's worst week since 'Liberation Day,' investors are increasingly seeking opportunities beyond traditional large-cap stocks. Penny stocks, despite their some…
Cerus raises 2025 product revenue guidance to $202M-$204M while accelerating IFC kit transition
Earnings Call Insights: Cerus Corporation (CERS) Q3 2025 MANAGEMENT VIEW * William Greenman, President, CEO & Chairman, stated Cerus "continues to build on its strong momentum, delivering another quarter of solid commercial, operational an…
Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 9/20/2025
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persiste…
As of late August 2025, the U.S. stock market has shown resilience, with major indices closing higher despite political uncertainties and upcoming earnings reports from key players like Nvidia. In such a climate, investors often seek oppor…
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Global Infrastructure ETF (Symbol: IGF) where we have detected an approximate $133.4 million dollar i…
Cerus raises 2025 revenue outlook to $200M-$203M driven by strong IFC demand
Earnings Call Insights: Cerus Corporation (CERS) Q2 2025 MANAGEMENT VIEW * William M. Greenman, President, CEO & Chairman, reported "another quarter of both solid commercial and product development execution" and highlighted the growing cl…
Cerus receives $7.2 million DoD contract amendment for trauma treatment
CONCORD, Calif. - Cerus Corporation (NASDAQ:CERS), a biotech company with a market capitalization of $260 million and showing revenue growth of ~13% over the last twelve months, has secured an additional $7.2 million contract amendment fro…
Introduction & Market Context Cerus Corporation (NASDAQ:CERS), a leader in blood safety technology, presented its Q4 2024 results and 2025 outlook in February, highlighting significant financial improvements and growth opportunities. The c…
Over the last 7 days, the United States market has risen 2.2%, and over the past 12 months, it is up by 13% with earnings forecasted to grow by 15% annually. For investors willing to explore beyond well-known companies, penny stocks — ofte…
Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 7/3/2025
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persiste…
Cerus advances European regulatory review for INTERCEPT RBC system
CONCORD, Calif. - Cerus Corporation (NASDAQ:CERS), a $283 million market cap biotech company whose stock has surged over 12% in the past week according to InvestingPro data, announced Wednesday that the European regulatory review for its I…
Cerus Corporation Celebrates World Blood Donor Day 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2025. In 2005, the World Health Assembly designated June 14th as World Blood Donor Day to recognize and thank…
In this article, we will take a detailed look at the12 Best Rising Penny Stocks To Buy. For a quick overview of such stocks, read our article 5 Best Rising Penny Stocks To Buy. Stocks are roaring after Nvidia posted yet another strong quar…
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood got back on track last year. The CEO and stock picker of Ark Invest's aggressive growth exchange-traded funds (ETFs) trounced the market in 2023 after fading awfully in back-to-back years. She publishes the daily transactions a…